{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:09:06Z","timestamp":1792782546285,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Milano","id":[{"id":"https:\/\/ror.org\/00wjc7c48","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal hematopoietic stem cell disorder characterized by uncontrolled complement-mediated intravascular hemolysis and a disproportionately high thromboembolic risk. Although terminal complement inhibition (CIT) has substantially modified the disease course, reducing thromboembolic events (TE), the residual risk remains elevated and evidence-based anticoagulation guidelines are lacking. To characterize real- world practice, we conducted a nationwide, cross-sectional survey involving 24 Italian Centers caring for 291 patients, evaluating strategies for primary antithrombotic prophylaxis (PAP), secondary prophylaxis (SAP), and management of breakthrough hemolysis (BTH). Marked heterogeneity emerged. PAP prior to CIT was routinely employed in only one-third of Centers, whereas an equal proportion did not use it; the remainder adopted risk-based approaches integrating thrombophilia traits or clone size. SAP was universally administered after TE, with 75% of Centers maintaining indefinite anticoagulation regardless of CIT response. Anticoagulation during BTH was likewise variable, with LMWH as the preferred agent and duration largely dictated by biochemical resolution. These findings demonstrate substantial inter-center variability, underscoring the lack of harmonized national frameworks. The results highlight the need for structured expert consensus and standardized clinical algorithms to optimize thrombosis prevention and management in PNH in the era of complement inhibition.<\/jats:p>","DOI":"10.1007\/s00277-026-07045-6","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:53:29Z","timestamp":1784127209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylaxis and management of thromboembolism in pnh patients: an italian survey"],"prefix":"10.1007","volume":"105","author":[{"given":"Anna Paola","family":"Iori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Notaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Frieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eros","family":"Di Bona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Vivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Patriarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Sau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Beggiato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Figuera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Bruna","family":"Greve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Achille","family":"Brioschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Laurino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Metafuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"D\u2019adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Maria","family":"Santeramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fattizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"7045_CR1","unstructured":"Parker C (2003) Paroxysmal nocturnal hemoglobinuria. In: Behrman RE (ed) National organization for rare disorders. NORD guide to rare disorders. Philadelphia: Lippincott Williams & Wilkins, pp 389\u2013390"},{"issue":"7","key":"7045_CR2","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00277-020-04052-z","volume":"99","author":"H Schrezenmeier","year":"2020","unstructured":"Schrezenmeier H, R\u00f6th A, Araten DJ, Kanakura Y, Larratt L, Shammo JM et al (2020) Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry. Ann Hematol 99(7):1505\u20131514. https:\/\/doi.org\/10.1007\/s00277-020-04052-z","journal-title":"Ann Hematol"},{"issue":"5","key":"7045_CR3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3324\/haematol.2013.093161","volume":"99","author":"H Schrezenmeier","year":"2014","unstructured":"Schrezenmeier H, Muus P, Soci\u00e9 G, Szer J, Urbano-Ispizua A, Maciejewski JP et al (2014) Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 99(5):922\u2013929. https:\/\/doi.org\/10.3324\/haematol.2013.093161","journal-title":"Haematologica"},{"issue":"8","key":"7045_CR4","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","volume":"112","author":"RP de Latour","year":"2008","unstructured":"de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M et al (2008) Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112(8):3099\u20133106. https:\/\/doi.org\/10.1182\/blood-2008-01-133918","journal-title":"Blood"},{"issue":"6","key":"7045_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2141.2011.08690.x","volume":"153","author":"L Luzzatto","year":"2011","unstructured":"Luzzatto L, Gianfaldoni G, Notaro R (2011) Management of paroxysmal nocturnal haemoglobinuria: a personal view. Br J Haematol 153(6):709\u2013720. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08690.x","journal-title":"Br J Haematol"},{"issue":"25","key":"7045_CR6","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","volume":"121","author":"A Hill","year":"2013","unstructured":"Hill A, Kelly RJ, Hillmen P (2013) Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 121(25):4985\u20134996. https:\/\/doi.org\/10.1182\/blood-2012-09-311381","journal-title":"Blood"},{"issue":"9","key":"7045_CR7","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/imj.13160","volume":"46","author":"G Soci\u00e9","year":"2016","unstructured":"Soci\u00e9 G, Schrezenmeier H, Muus P, Lisukov I, R\u00f6th A, Kulasekararaj A et al (2016) Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry. Intern Med J 46(9):1044\u20131053. https:\/\/doi.org\/10.1111\/imj.13160","journal-title":"Intern Med J"},{"issue":"12","key":"7045_CR8","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","volume":"110","author":"P Hillmen","year":"2007","unstructured":"Hillmen P, Muus P, D\u00fchrsen U, Risitano AM, Schubert J, Luzzatto L et al (2007) Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 110(12):4123\u20134128. https:\/\/doi.org\/10.1182\/blood-2007-06-095646","journal-title":"Blood"},{"issue":"12","key":"7045_CR9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1182\/blood.2023021762","volume":"143","author":"RJ Kelly","year":"2024","unstructured":"Kelly RJ, Holt M, Vidler J, Arnold LM, Large J, Forrest B et al (2024) Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria. Blood 143(12):1157\u20131166. https:\/\/doi.org\/10.1182\/blood.2023021762","journal-title":"Blood"},{"issue":"25","key":"7045_CR10","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M et al (2011) Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 117(25):6786\u20136792. https:\/\/doi.org\/10.1182\/blood-2011-02-333997","journal-title":"Blood"},{"issue":"1","key":"7045_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2141.2004.04992.x","volume":"126","author":"VM Moyo","year":"2004","unstructured":"Moyo VM, Mukhina GL, Garrett ES, Brodsky RA (2004) Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol 126(1):133\u2013138. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.04992.x","journal-title":"Br J Haematol"},{"issue":"3","key":"7045_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000126763.68170.46","volume":"83","author":"JI Nishimura","year":"2004","unstructured":"Nishimura JI, Kanakura Y, Ware RE, Shichishima T, Nakakuma H, Ninomiya H et al (2004) Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan. Med (Baltim) 83(3):193. https:\/\/doi.org\/10.1097\/01.md.0000126763.68170.46","journal-title":"Med (Baltim)"},{"issue":"9027","key":"7045_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0140-6736(95)12360-1","volume":"348","author":"G Soci\u00e9","year":"1996","unstructured":"Soci\u00e9 G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C et al (1996) Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Lancet 348(9027):573\u2013577. https:\/\/doi.org\/10.1016\/S0140-6736(95)12360-1","journal-title":"Lancet"},{"issue":"3","key":"7045_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3324\/haematol.2011.049767","volume":"97","author":"DJ Araten","year":"2012","unstructured":"Araten DJ, Notaro R, Thaler HT, Kernan N, Boulad F, Castro-Malaspina H et al (2012) Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature. Haematologica 97(3):344\u2013352. https:\/\/doi.org\/10.3324\/haematol.2011.049767","journal-title":"Haematologica"},{"issue":"3","key":"7045_CR15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1538-7836.2007.02379.x","volume":"5","author":"PD Ziakas","year":"2007","unstructured":"Ziakas PD, Poulou LS, Rokas GI, Bartzoudis D, Voulgarelis M (2007) Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 5(3):642\u2013645. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02379.x","journal-title":"J Thromb Haemost"},{"issue":"2","key":"7045_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2141.2008.07183.x","volume":"142","author":"J Schubert","year":"2008","unstructured":"Schubert J, Hillmen P, R\u00f6th A, Young NS, Elebute MO, Szer J et al (2008) Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 142(2):263\u2013272. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07183.x","journal-title":"Br J Haematol"},{"key":"7045_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/JBM.S339660","volume":"13","author":"B Fattizzo","year":"2022","unstructured":"Fattizzo B, Cavallaro F, Oliva EN, Barcellini W (2022) Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective. J Blood Med 13:327\u2013335. https:\/\/doi.org\/10.2147\/JBM.S339660","journal-title":"J Blood Med"},{"issue":"1","key":"7045_CR18","doi-asserted-by":"publisher","first-page":"2329030","DOI":"10.1080\/16078454.2024.2329030","volume":"29","author":"D Dingli","year":"2024","unstructured":"Dingli D, De Castro Iii C, Koprivnikar J, Kulasekararaj A, Maciejewski J, Mulherin B et al (2024) Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria. Hematol Amst Neth 29(1):2329030. https:\/\/doi.org\/10.1080\/16078454.2024.2329030","journal-title":"Hematol Amst Neth"},{"issue":"36","key":"7045_CR19","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM et al (2024) 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 45(36):3314\u20133414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"issue":"10","key":"7045_CR20","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","volume":"78","author":"MG Tektonidou","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N et al (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78(10):1296\u20131304. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7045_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/jth.12485","volume":"12","author":"T van der Hulle","year":"2014","unstructured":"van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV (2014) Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 12(3):320\u2013328. https:\/\/doi.org\/10.1111\/jth.12485","journal-title":"J Thromb Haemost"},{"issue":"10","key":"7045_CR22","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1182\/blood-2003-01-0009","volume":"102","author":"C Hall","year":"2003","unstructured":"Hall C, Richards S, Hillmen P (2003) Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 102(10):3587\u20133591. https:\/\/doi.org\/10.1182\/blood-2003-01-0009","journal-title":"Blood"},{"issue":"2","key":"7045_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1182\/blood.2024023988","volume":"144","author":"C Gurnari","year":"2024","unstructured":"Gurnari C, Awada H, Pagliuca S, Dima D, Ullah F, Kawashima N et al (2024) Paroxysmal nocturnal hemoglobinuria\u2013related thrombosis in the era of novel therapies: a 2043-patient-year analysis. Blood 144(2):145\u2013155. https:\/\/doi.org\/10.1182\/blood.2024023988","journal-title":"Blood"},{"key":"7045_CR24","doi-asserted-by":"publisher","unstructured":"Biglietto M, Faccini AL, Micozzi J, Salvatori M, Antonacci M, Rocca UL et al (2025) Direct oral anticoagulants as secondary prophylaxis of venous thromboembolism in paroxysmal nocturnal hemoglobinuria: an Italian monocentric experience. J Thromb Thrombolysis 9. https:\/\/doi.org\/10.1007\/s11239-025-03124-z","DOI":"10.1007\/s11239-025-03124-z"},{"issue":"22","key":"7045_CR25","doi-asserted-by":"publisher","first-page":"12104","DOI":"10.3390\/ijms252212104","volume":"25","author":"S Kokoris","year":"2024","unstructured":"Kokoris S, Polyviou A, Evangelidis P, Grouzi E, Valsami S, Tragiannidis K et al (2024) Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment. Int J Mol Sci 25(22):12104. https:\/\/doi.org\/10.3390\/ijms252212104","journal-title":"Int J Mol Sci"},{"issue":"S1","key":"7045_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/ijlh.14281","volume":"46","author":"F Versino","year":"2024","unstructured":"Versino F, Fattizzo B (2024) Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy. Int J Lab Hematol 46(S1):43\u201354. https:\/\/doi.org\/10.1111\/ijlh.14281","journal-title":"Int J Lab Hematol"},{"issue":"10","key":"7045_CR27","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ajh.21506","volume":"84","author":"A Emadi","year":"2009","unstructured":"Emadi A, Brodsky RA (2009) Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria. Am J Hematol 84(10):699\u2013701. https:\/\/doi.org\/10.1002\/ajh.21506","journal-title":"Am J Hematol"},{"issue":"10","key":"7045_CR28","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1182\/blood.2019003812","volume":"137","author":"RA Brodsky","year":"2021","unstructured":"Brodsky RA (2021) How I treat paroxysmal nocturnal hemoglobinuria. Blood 137(10):1304\u20131309. https:\/\/doi.org\/10.1182\/blood.2019003812","journal-title":"Blood"},{"issue":"11","key":"7045_CR29","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/ajh.70032","volume":"100","author":"B Fattizzo","year":"2025","unstructured":"Fattizzo B, Pedone GL, Metafuni E, Beggiato E, Giai V, Natalie Oliva E et al (2025) Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience. Am J Hematol 100(11):1963\u20131971. https:\/\/doi.org\/10.1002\/ajh.70032","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07045-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07045-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07045-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:08:48Z","timestamp":1792123728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07045-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7045"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07045-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8777240\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Since this research consisted of a survey addressed to healthcare professionals (referents of Italian PNH hub centers) regarding clinical management protocols and did not involve patients, clinical interventions, or the use of identifiable human biological material, formal approval by an Ethics Committee was not required according to national and institutional guidelines.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Formal informed consent was not applicable as no human participants (patients) were involved. Completion and submission of the survey by the healthcare professionals were considered as implied consent to participate in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"458"}}